secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001628280-23-017025
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q1 net sales $86.3M (+14% YoY), net loss $22.3M, raises FY23 guidance
--------------------------------------------------------------------------------

- Net sales $86.3M (+14% YoY); consumables +21% YoY led by Americas +34% and EMEA +35% ex-Russia.
- Net loss $22.3M vs net income $31.5M in prior year; adjusted EBITDA loss $0.5M vs +$1.2M.
- GAAP gross margin 62.7% (down from 67.5%); adjusted gross margin 70.0% (down from 71.3%).
- Company raises FY2023 net sales guidance and reaffirms EBITDA margin and 2025 long-term targets.
- Syndeo international launch planned for Q2 2023; China COVID shutdowns affected Jan-Feb but rebound in March.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/0001628280-23-017025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/skin-20230510.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-017025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer